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Abstract The Fet3 protein in Saccharomyces cerevisiae and
mammalian ceruloplasmin are multicopper oxidases (MCO)
that are required for iron homeostasis via their catalysis of
the ferroxidase reaction, 4Fe2++O2+4H
+C4Fe3++2H2O. The
enzymes may play an essential role in copper homeostasis since
they exhibit a strikingly similar kinetic activity towards Cu1+ as
substrate. In contrast, laccase, an MCO that exhibits weak
activity towards Fe2+, exhibits a similarly weak activity towards
Cu1+. Kinetic analyses of the Fet3p reaction demonstrate that
the ferroxidase and cuprous oxidase activities are due to the
same electron transfer site on the enzyme. These two ferroxi-
dases are fully competent kinetically to play a major role in
maintaining the cuprous^cupric redox balance in aerobic organ-
isms.
/ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Ferroxidases are a group of multicopper oxidases (MCO)
that exhibit an activity towards Fe2þ not shared by the other
members of this family of copper proteins [1,2]. The copper
proteins in this family are distinguished by having three dis-
tinct copper sites, Cu(II) types 1, 2 and 3. All of these enzymes
couple the oxidation of four molecules of a one-electron do-
nor substrate with the reduction of one molecule of dioxygen
to 2H2O. The oxidation of the reducing substrate occurs at
the type 1 Cu(II) while the reduction of O2 occurs at the type
2, type 3 grouping of copper atoms known as the trinuclear
cluster [2].
The substrate speci¢city of these enzymes is quite broad.
For example, over 50 substrates have been examined in the
reaction catalyzed by ceruloplasmin (Cp), a mammalian MCO
that is abundant in the serum and in interstitial £uid, as in the
brain [3^5]. One striking speci¢city that has been character-
ized is the activity that only some MCOs exhibit towards Fe2þ
as reducing substrate. The oxidation by O2 of ferrous iron is
known as the ferroxidase reaction [1]. This catalysis is not
restricted to this group of MCOs; it is exhibited also by fer-
ritin in the process of iron core formation in this protein [6].
Cp and the yeast plasma membrane protein, Fet3p [7^10],
are the best characterized ferroxidases, as these speci¢c MCOs
are called. Genetic studies in both mammals and yeast have
established that the activity of these enzymes is essential to
iron homeostasis in their respective organisms. For example,
Cp knock-out mice exhibit the pathophysiology characteristic
of the genetic disorder aceruloplasminemia; this disease is
marked by severe neurologic de¢cits [3,11,12]. In yeast, the
action of Fet3p on Fe2þ is coupled to the transport of the
Fe3þ product into the yeast cell ; Fet3p ‘knock-out’ yeast are
therefore iron-de¢cient [7,13]. This ferroxidase activity of
these copper enzymes explains the large body of literature
that has reported on an apparent link between copper and
iron metabolism in eukaryotes [3,4].
The pathophysiology in mammals associated with a de¢cit
of Cp activity has commonly been attributed, in part, to an
oxidative stress that results from a dys- or mislocalization of
iron [3,14^16]. This inference is consistent with the reactivity
of Fe2þ, in particular, in reaction with O2 and its reduction
products, most importantly, H2O2. The one-electron reduc-
tion by Fe2þ of O2 produces the superoxide radical while
the reaction with H2O2 produces the hydroxyl radical [17].
The latter species, in particular, is strongly cytotoxic. Cu1þ
is equally adept at supporting the one-electron reduction
(pro-oxidant) processes that produce these potentially damag-
ing radical species [18]. Copper toxicity is well-known and, at
least in part, it is associated with an oxidative stress, also [19].
Signi¢cantly, copper toxicity in yeast is exacerbated by the
absence of Fet3p in the plasma membrane [20,21].
Recognizing that the lower valent forms of redox active
metals like copper and iron are well-known as pro-oxidants
due to their support of the one-electron redox chemistry noted
above, we have considered the possibility that ferroxidases
may play a protective as well as strictly iron metabolic role
in aerobes. With iron, this cytoprotective role is di⁄cult to
separate from these enzymes’ role in iron homeostasis per se.
However, these enzymes have no comparable function in cop-
per metabolism. Thus, demonstrating their activity towards
Cu1þ as substrate would provide the basis for proposing
that this activity is expressed in vivo and thereby plays a
critical role in the suppression of copper and iron cytotoxicity.
This cuprous oxidase activity is analytically characterized here
for the ¢rst time.
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2. Materials and methods
2.1. Enzymes
Human ceruloplasmin (hCp) [22] and Rhus vernicifera laccase [23]
were obtained from the Solomon laboratory (Stanford University,
Palo Alto, CA, USA). Well-characterized, soluble forms of wild
type Fet3p, and a type 1 Cu(II)-depleted Fet3p mutant, Fet3p
(C484S), were puri¢ed as described [9,10]. All protein samples used
in the following kinetic analyses were homogeneous as determined by
sodium dodecyl sulfate gel electrophoresis.
2.2. Kinetic analyses
All kinetic analyses were based on oxygen consumption using an
Oxygraph (Hansatech, www.hansatech-instruments.co.uk) [24]. Rates
of O2 uptake were evaluated using the OXYG32 software provided by
Hansatech. All initial velocity, v versus [S] data were subsequently
analyzed by direct ¢tting to the Michaelis^Menten equation using
Prism software from GraphPad (GraphPad Software, San Diego,
CA, USA). Ferrous ammonium sulfate (Sigma, St. Louis, MO,
USA) was used for kinetic analysis of the ferroxidase reaction; cuprous
chloride (Alfa Aesar, Ward Hill, MA, USA) was used to measure
cuprous oxidase activity. The stock solution of the former substrate
was freshly prepared in nitrogen-purged bu¡er; the stock solution of
the latter substrate was in acetonitrile. All transfers from these stock
solutions were done using gas-tight syringes. The bu¡er used for O2
uptake measurements was air-saturated, pH 5.0, 0.1 M MES that, in
all cases, contained 5% acetonitrile (¢nal v/v percent). Laccase was
assayed also with p-phenylenediamine (Sigma) as a check on its oxi-
dase activity. This substrate was recrystallized before use and stored
under N2. To test whether Cu1þ and Fe2þ were being turned over at
the same active site in Fet3p, O2 uptake measurements were made in
mixtures of the two substrates at various ratios. These measured ve-
locities were then compared to the velocities predicted for single active
site versus two active sites kinetic models [25]. These predicted veloc-
ities were generated in the program Origin (OriginLab, Northampton,
MA, USA) using the kinetic constants determined in this work
(Table 1).
3. Results
3.1. Steady-state kinetic analysis of the cuprous oxidase
reaction catalyzed by Fet3p and hCp
A standard v versus [S] analysis of the oxidation of cuprous
ion by these two ferroxidases was carried out. The experimen-
tal data for the Fet3p reaction are given in Fig. 1A (closed
circles); the curve represents the theoretical ¢t based on the
¢tted kinetic constants given in Table 1. The data for the hCp-
catalyzed reaction behaved comparably as shown in Fig. 1A
(open circles); the ¢tted values for the kinetic constants for
this reaction are given in Table 1, also. The reaction mixtures
with Cu1þ contained 5% (v/v) acetonitrile, the solvent for
stock solutions of cuprous chloride. Consequently, the
steady-state ferroxidase kinetics for Fet3p and hCp were de-
termined in the same solvent mixture. These ¢ts are shown in
Fig. 1B (closed and open circles, respectively). The corre-
sponding sets of ¢tted kinetic constants are tabulated in Table
1, also.
In contrast to the two ferroxidases, even at 300 WM Cu1þ,
laccase exhibited little activity with this substrate (Fig. 1A,
open triangles). This [Cu1þ] was equivalent to at least 9KM
for either of the ferroxidases (Table 1) indicating that for
laccase, the KM for Cu1þ was ca. 1 mM or greater, or the
kcat was ca. 2 min31 or less, based on the sensitivity of our O2-
electrode system. Laccase was essentially without activity to-
wards Fe2þ, also (Fig. 1B, open triangles). Assay of the lac-
case using p-phenylenediamine as substrate demonstrated that
the enzyme preparation used had an oxidase activity compa-
rable to that reported in the literature (data not shown). These
data indicate that the ferroxidases, speci¢cally, share a cuprous
oxidase activity that is not exhibited by an MCO known to
have a strongly diminished reactivity with Fe2þ as substrate
[10].
3.2. The ferroxidase and cuprous oxidase reactions catalyzed
by Fet3p occur at the same enzyme active site
To demonstrate that the apparent metallo-oxidase activity
of Fet3p originated from one redox site, speci¢cally, the type
1 Cu(II), two experiments were performed. First, kinetic com-
petition between Cu1þ and Fe2þ was determined in the Fet3p
reaction by measuring O2 uptake as a function of [Cuþ1] and
[Fe2þ] in the reaction mixture. Brie£y, if two substrates are
turned over at the same site, the velocity measured in a mix-
ture of the two will be less than the sum of the velocities
measured if each is present separately. This is because of the
substrate competition due to one of the substrates on the
measured velocity due to the other. In contrast, if the sub-
Table 1
Kinetic constants for the cuprous oxidase and ferroxidase reactions
of Fet3p and hCp
Enzyme KM (WM) kcat (min31)
Cu1þ Fe2þ Cu1þ Fe2þ
Fet3p 37.9S 3.6 5.4S 0.8 79.2S 2.7 63.9S 2.5
hCp 36.8S 5.1 8.3S 1.5 22.5S 0.8 30.3S 1.6
Fig. 1. Steady-state kinetic analysis of cuprous oxidase and ferroxi-
dase reactions catalyzed by Fet3p, hCp and laccase. A: The cuprous
oxidase reaction: wild type Fet3p, closed circles; hCp, open circles;
laccase, open triangles; Fet3p(T1D) mutant, crosses. B: The ferroxi-
dase reaction: Fet3p, closed circles; hCp, open circles; laccase, open
triangles; Fet3p(T1D) mutant, crosses. Note that the experimental
values are given in molecular velocities, vmeasured/[E]. This normalizes
the measured velocities so that they can be directly compared
among the various enzyme species used. These data were ¢t directly
to the Michaelis^Menten equation generating the traces shown in
the ¢gure and the ¢tted values for KM and kcat that are given in Ta-
ble 1.
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strates are turned over at separate sites, then the velocity from
a mixture will equal this sum irrespective of the substrates’
concentrations. These two possibilities are analytically de-
scribed by Eqs. 1 and 2, respectively [25].
V t ¼ Vmax Fe ½Fe
2þ
Km Feð1þ ½Cu1þ=Km CuÞ þ ½Fe2þ
þ Vmax Cu ½Cu
1þ
Km Cuð1þ ½Fe2þ=Km FeÞ þ ½Cu1þ ð1Þ
V t ¼ Vmax Fe ½Fe
2þ
Km Fe þ ½Fe2þ þ
Vmax Cu ½Cu1þ
Km Cu þ ½Cu1þ ð2Þ
The results of this analysis are given in Fig. 2. The exper-
imental points (open circles) are compared to the ¢rst of these
models, Eq. 1 (single site, lower curve) and to the second of
these models, Eq. 2 (two sites, upper curve). Clearly, the data
conform to the former, same site model indicating that the
two metal ions are turned over competitively at the same
redox site on the enzyme. To emphasize: what distinguishes
this model from simple, two site ones is that turnover in the
presence of both substrates is always less than that in the
presence of only one when at the same total concentration.
This concentration dependence arises distinctly from the
(1+[Me2þ]/KMe) terms in the denominators in Eq. 1 that de-
scribe the mutually exclusive binding of the two metal ions to
a single active site on the enzyme.
This site is well-known to be the type 1 Cu(II). For exam-
ple, a mutant of Fet3p, C484S, lacks the type 1 Cu(II) since
C484 is one of the ligands to the copper at this site [10]. This
type 1-depleted Fet3p (designated Fet3pT1D, see [10]) is in-
active with Fe2þ as substrate (Fig. 1B, crosses, and [10]) ; it is
inactive with Cu1þ as well (Fig. 1A, crosses). Other copper
site-depleted mutant forms of Fet3p [10,26,27] were similarly
inactive with both Fe2þ and Cu1þ as substrate (latter data not
shown). Thus, the cuprous oxidase activity of Fet3p is not
obviously due to some non-speci¢c site on the protein with
kinetics that fortuitously mimic how single site kinetics would
behave in the competition experiments above.
4. Discussion
The ferroxidases Fet3p and hCp are robust catalysts of the
oxidation of cuprous to cupric copper. The only strong di¡er-
ence in this cuprous oxidase reaction in comparison to the
ferroxidase one is that the KM for Cu1þ is generally larger
for these two ferroxidases. The inferred weaker binding of
Cu1þ in comparison to Fe2þ can be ascribed to the +1 charge
di¡erence in the latter substrate. The binding of metal cations
to hCp has been localized to a region of the protein that
presents an electrostatic surface that is overall negative, bind-
ing that has been ascribed speci¢cally to a coordination sphere
that includes a preponderance of acidic amino acid side chains
[28]. Consistent with the di¡erence in KM values for Fe2þ and
Cu1þ in the hCp reaction is the fact that in the hCp crystal,
copper bound to this region of the protein is ‘labile’ and is
displaced by iron. Mutagenesis studies in Fet3p have impli-
cated two acidic residues in Fe2þ binding to this protein as
well [24,29]. In contrast, laccase has a substrate binding site
hospitable for large, bulky aromatic reductants, not for a di-
or trivalent metal ion [30]. This structural di¡erence can ac-
count, at least in part, for the speci¢city that hCp and Fet3p
in comparison to laccase exhibit, a speci¢city that we now
have shown extends to Cu1þ.
As noted, there are no data that suggest a role for catalysis
of Cu1þ oxidation in copper metabolism comparable, for ex-
ample, to the essential role that Fet3p and its orthologs play
in high a⁄nity iron uptake in yeasts [31] and, apparently, in
photosynthetic green algae [32]. In fact, high a⁄nity copper
uptake in eukaryotes appears to rely most heavily on the Ctr1
protein that, in turn, appears to use Cu1þ as substrate [33].
However, the Cu1þ for uptake is most likely generated in situ
by the reduction of environmental Cu2þ catalyzed by a plas-
ma membrane metalloreductase. In S. cerevisiae this is the
Fre1 protein [34] ; in the mammalian epithelial cell, this would
be the Dcytb protein [35].
That is, eukaryotes are producing quantities of Cu1þ in the
course of normal copper metabolism. As an enzyme product,
this Cu1þ has the potential to equilibrate with bulk solvent,
that is, it can be considered ‘free’. This certainly is the case in
the yeast Cu2þ reduction/copper uptake system where cuprous
copper for uptake can come directly from the bulk solvent,
and not necessarily from Fre1p [36]. In short, eukaryotic cells
are normally producing a fairly aggressive pro-oxidant. Our
data demonstrate that the cuprous oxidase activity of Cp in
mammals, or of the Fet3 protein in yeast, is kinetically com-
petent to maintain cuprous ion ‘homeostasis’ with regard to
this pro-oxidant’s steady-state concentration. Note, however,
that this picture applies to a cell’s ‘extracellular’ compartment,
not to any intracellular one. O’Halloran and his co-workers
have examined in some detail the state of intracellular copper
and have concluded that there is little if any ‘free’ copper [37].
In contrast to the situation at the cell surface, copper in cells
is essentially all protein-bound, e.g. to copper chaperones and,
in copper excess, to metallothioneins. In short, our data sug-
gest that the eukaryotic cell has two lines of defense with
Fig. 2. Steady-state kinetic analysis of Cu1þ, Fe2þ competition in
the Fet3p reaction. O2 uptake data were obtained as described in
Fig. 1 using the mixtures of [Cu1þ] and [Fe2þ] indicated in the plot.
The theoretical curves for Eqs. 1 and 2 (text) were generated in Ori-
gin (OriginLab) using the kinetic constants for the ferroxidase and
cuprous oxidase reactions given in Table 1 for Fet3p. The lower
curve is for Eq. 1, the case in which the two substrates react com-
petitively at the same site; the upper curve is for Eq. 2, the case in
which the two substrates react independently at two separate, non-
interacting sites [25].
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regard to copper: one that is redox-based to deal with ‘free’,
environmental copper, and one that is chelator-based, for
metabolic copper in the cell.
The CueO protein, an MCO from Escherichia coli that is
encoded within a copper resistance operon in the genome of
this bacterium, is a ferroxidase localized to the periplasmic
space that exhibits a pattern of substrate reactivity similar
to that recorded for Cp [38^40]. Three groups working with
this protein and its encoding cue system (for Cu e¥ux) have
suggested that CueO (previously known as the yakK gene
product) could contribute to copper resistance by acting as
a cuprous oxidase thus shifting the Cu2þ/Cu1þ ratio towards
Cu2þ. In this model, the cupric ion would be less readily taken
into the cell in addition to its being a weaker pro-oxidant,
thus explaining the cytoprotective e¡ect of the CueO protein.
However, one of these groups reported that despite a sub-
strate reactivity pro¢le comparable to that of hCp, including
its reactivity with Fe2þ, CueO exhibited no oxidase activity
with Cu1þ as substrate [40]. Therefore, the role of cuprous
oxidase activity in copper homeostasis in prokaryotes remains
unresolved.
On the other hand, two labs have reported that deletion of
FET3 in S. cerevisiae results in a copper sensitivity not seen in
wild type yeast [20,21]. One group suggested that as a copper
protein, Fet3p might play some role in sequestering copper,
thus suppressing its cytotoxic potential [21]. The other re-
searchers noted that the expression of low a⁄nity metal trans-
porters was increased in a vfet3 strain. Therefore, they sug-
gested that the increased copper sensitivity in this strain might
be due to an increased copper accumulation via these other
pathways [20]. Neither group considered the possibility that
Fet3p played a catalytic role in maintenance of copper ho-
meostasis. The kinetic analyses described here provide evi-
dence in support of this possibility.
In fact, recent data from the Zhu lab appear to link the
cuprous oxidase activity that we have described here with
protection against copper stress in yeast [41]. Zhu and his
co-workers demonstrated that the copper sensitivity exhibited
by yeast strains carrying a deletion of the FET3 gene was
suppressed in this background by deletion of the FRE1 gene
that encodes the predominant cell surface metalloreductase in
S. cerevisiae. In contrast, over-production of Fre1p and thus
of plasma membrane Cu2þ reductase activity strongly in-
creased the copper sensitivity of vfet3 as well as wild type
yeast strains. Since this copper sensitivity was completely in-
dependent of copper uptake and, therefore, of abnormal intra-
cellular copper, these workers concluded that extracellular,
Fre1p-generated Cu1þ was the dominant cytotoxic agent in
copper sensitivity. In turn, the steady-state level of this
Cu1þ was reduced by its oxidation to Cu2þ by Fet3p via the
cuprous oxidase reaction characterized in this report.
The suggestion that Fet3p plays a speci¢c physiologic role
in yeast copper metabolism via its four-electron reduction of
O2 to water using 4Cu1þ as substrate is predicated on the
assumption that there is a signi¢cant steady-state level of re-
duced metal species at the cell surface due to the Fre1p reac-
tion. This situation would require that the relative velocities of
the two processes involved in copper uptake ^ reduction and
transport ^ were VRsVT. In yeast, these reduction and up-
take values are 7 and 0.7 nmol Cu/min/mg cell protein, re-
spectively [36] indicating that there is ‘excess’ Cu1þ produced
as pro-oxidant and as potential substrate for Fet3p. This ‘ex-
cess’ is increased ca. eight-fold in yeast strains that over-pro-
duce Fre1p; as noted, these strains exhibit a correspondingly
exaggerated sensitivity to copper [36].
The fact that hCp also exhibits cuprous oxidase activity
argues that this protein and its homolog, hephaestin (Hp),
could play a comparable copper-protective role in mammals.
There are three ferroxidases in mammals: the soluble, secreted
Cp; a glycosyl phosphatidylinositol-anchored form of Cp
(GPI-Cp) identi¢ed in the brain [42], retina [43] and Sertoli
cells [44] ; and Hp, a type 1 membrane protein found in the
intestinal epithelium [45]. Based on their homology and on the
results here, the latter two proteins, like Cp itself, are most
likely cuprous oxidases, also. Thus, all three may well con-
tribute to the suppression of nascent copper toxicity in mam-
mals due to the accumulation of Cu1þ. Of note is the fact that
increased oxidative stress is a cellular phenotype linked to
aceruloplasminemia. This stress has been described in brain
[46] and retina [47] while oxidative stress in the latter tissue
associated with photic injury is linked to a strong induction of
mRNA for both the soluble and GPI-linked forms of Cp [43].
Also, GPI-Cp is anchored to the extracellular face of the
plasma membrane, an orientation identical to that of Fet3p,
and, therefore, is well-positioned to scavenge Cu1þ produced
at or near this membrane surface [44].
Cu1þ is a pro-oxidant comparable in activity to Fe2þ. One
example of this is the fact that in complex with ADP, Cu2þ
exhibited 70% of the activity of Fe3þ in the peroxidation of
rat liver microsomal phospholipids with dopamine and dioxy-
gen supporting the catalytic redox cycle [14]. This type of lipid
peroxidation has been proposed as a possible mechanism of
iron neurotoxicity, as is implied in the neural pathophysiology
observed in aceruloplasminemia [11,12,15,16]. In fact, Cp
blocked lipid peroxidation in this in vitro assay with Fe3þ-
ADP as catalyst [14]. Unfortunately, its e¡ect on the Cu2þ-
ADP-catalyzed reaction was not reported. On the other hand,
in a brief report on the pathophysiology in patients with acer-
uloplasminemia, Gitlin and co-workers may have demon-
strated a protective role for hCp in cuprous ion-catalyzed lipid
peroxidation [48]. However, to date, there are no explicit re-
ports of studies on possible mechanisms of the copper neuro-
toxicity that would reasonably follow in Cp de¢ciency if Cp
and its congeners played an essential role in copper homeo-
stasis as cuprous oxidases. Hopefully, the results described
here, and those reported by Shi et al. [41], will encourage
others to embark on such studies.
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